JUVARIS BIO THERAPEUTICS INC — Form D
JUVARIS BIO THERAPEUTICS INC of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-24. The offering totals $25.1M, of which $15.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-09-24
- Form: D
- Accession: 0001347758-09-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $25.1M
- Amount sold: $15.1M
- Remaining: $10.0M
- Investors: 3
- Date of first sale: 2009-09-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-84205
Issuer
- Name: JUVARIS BIO THERAPEUTICS INC
- CIK: 0001347758
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 866 MALCOLM ROAD, SUITE 100, BURLINGAME, CA, 94010
- Phone: 650-697-8828
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Michael Ross | Director | South San Francisco, CA |
| Kimberlee Gonzaga | Executive Officer | Burlingame, CA |
| Grant E Pickering | Director | Foster City, CA |
| Grant E Pickering | Executive Officer | Foster City, CA |
| Thomas P Monath | Director | Bedford, MA |
| Lewis T Williams | Director | South San Francisco, CA |
| Michael L Ross | Director | Boston, MA |
| Kimberlee E Gonzaga | Executive Officer | Burlingame, CA |
| Carol L Brosgart | Director | Burlingame, CA |
Other filings by this issuer (1)
More